From targets to treatments: a review of molecular targets in pancreatic neuroendocrine tumors.


Pancreatic neuroendocrine tumors (pancreatic NET) are relatively rare, slowly growing tumors, although their incidence is increasing, and patients may survive for several years with metastatic disease. Apart from symptomatic relief, there have been few treatment options for these tumors in the past. More recently, investigators have explored the potential… (More)
DOI: 10.1159/000329386

5 Figures and Tables


  • Presentations referencing similar topics